Rossari Biotech peers

Companies like Rossari Biotechlatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

ROSSARI₹415.00

Rossari Biotech Limited

· Chemicals
₹ CrorePeersNOCILHSCLNAVINFLUORDDEVPLSTIKCHEMPLASTSTATACHEMAARTIINDJGCHEMMcap ₹2,298 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ROSSARI
FY26
NOCIL
FY26
HSCL
FY26
NAVINFLUOR
FY26
Peer
Average
Valuation — at last close
P/E◆ 15.40×44.28×32.76×58.47×45.17× -66%
P/B1.72×◆ 1.39×5.29×9.85×5.51× -69%
EV/EBITDA◆ 9.02×21.05×25.86×36.11×27.67× -67%
Market Cap₹2,298 Cr₹2,463 Cr₹24,920 Cr₹39,155 Cr₹22,179 Cr -90%
Growth
Revenue CAGR 3Y13.11%-6.94%3.76%◆ 16.84%4.55% +188%
Revenue CAGR 5Y◆ 27.57%7.10%22.65%22.95%17.57% +57%
Net Income CAGR 3Y11.63%-28.02%◆ 51.80%20.93%14.90% -22%
Revenue YoY (latest Q)19.02%33.17%◆ 57.93%57.00%49.37% -61%
Net Income YoY (latest Q)5.51%◆ 98.43%31.33%81.46%70.41% -92%
Profitability
EBITDA Margin11.93%7.73%20.64%◆ 32.64%20.34% -41%
Net Income Margin6.23%4.27%16.20%◆ 20.02%13.50% -54%
Return on Common Equity11.85%3.15%17.83%◆ 20.11%13.70% -13%
Return on Capital Employed14.47%2.41%19.60%◆ 20.21%14.07% +3%
Return on Assets7.13%2.67%◆ 13.78%11.84%9.43% -24%
Credit & Quality
Total Debt/Equity0.31×◆ 0.00×0.16×0.31×0.16× +98%
Interest Coverage7.24×◆ 33.04×13.89×7.91×18.28× -60%
Scale — latest FY
Revenue / Total Income₹2,396 Cr₹1,303 Cr₹4,661 Cr₹3,314 Cr₹3,093 Cr -23%
Net Income₹149 Cr₹55.6 Cr₹755 Cr₹664 Cr₹491 Cr -70%
Total Assets₹2,289 Cr₹2,111 Cr₹6,306 Cr₹6,379 Cr₹4,932 Cr -54%
EPS₹26.95₹3.33₹15.08₹130.67₹49.69 -46%
Book Value per Share₹240.74₹106.18₹93.29₹775.53₹325 -26%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.